Thalamic NMDA transmission in a genetic model of absence epilepsy in rats

• Published in: Epilepsy research Vol. 25; no. 1; pp. 11 - 19
• Main Authors: Koerner, C., Danober, L., Boehrer, A., Marescaux, C., Vergnes, M.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.1996
• Subjects: Absence seizures; Animals; Disease Models, Animal; Dizocilpine Maleate - pharmacology; Epilepsy; Epilepsy, Absence - physiopathology; Glutamate; Male; Models, Genetic; N-Methylaspartate - pharmacology; NMDA; Rat; Rats; Thalamus; Thalamus - drug effects; NMDA; Absence seizures; Thalamus; Rat; Glutamate; Epilepsy
• ISSN: 0920-1211; 1872-6844
• DOI: 10.1016/0920-1211(96)00015-0

In the selected strain of GAERS Wistar rats (Genetic Absence Epilepsy Rats from Strasbourg), all animals present spontaneously recurrent absence seizures characterized by bilateral and synchronous generalized spike-and-wave discharges (SWD) accompanied by behavioural arrest. SWD depend on a thalamo-cortical network connecting the reticular and relay nuclei of the thalamus and their cortical projection areas. This loop involves both GABAergic and glutamatergic synapses. In the present study, we investigated the implication of NMDA transmission in the genesis of absence seizures in GAERS. Intra-peritoneal or intra-cerebroventricular injections of NMDA, the competitive NMDA antagonist CGP 40116, the non-competitive NMDA antagonist (+)-MK 801 and the antagonist of the glycine modulatory site 5,7-dichlorokynurenic acid dose-dependently suppressed SWD. Bilateral infusions of the same drugs in the lateral relay nuclei of the thalamus had similar suppressive effects. Intra-cerebroventricular or intrathalamic administration of d-serine, an agonist of the glycine modulatory site, had no effect on SWD. These data show that NMDA neurotransmission, especially within the thalamus, plays a major role in the control of absence seizures in GAERs. Disregulation of NMDA-mediated transmission by NMDA or antagonists, interacting with various sites of the receptor complex, may suppress the thalamo-cortical oscillatory activity which underlies SWD.